ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AKBA Akebia Therapeutics Inc

1.44
0.14 (10.77%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Akebia Therapeutics Inc AKBA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.14 10.77% 1.44 08:54:53
개장가 저가 고가 종가 전일 종가
1.34 1.32 1.42 1.37 1.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:30PRNUSAkebia Therapeutics to Report First Quarter 2024 Financial..
02/05/202405:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
03/04/202405:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
28/03/202409:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
15/03/202405:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
12/03/202406:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
02/03/202407:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01/03/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:32EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:28EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:27EDGAR2Form 144 - Report of proposed sale of securities
28/02/202408:19EDGAR2Form 144 - Report of proposed sale of securities
28/02/202408:14EDGAR2Form 144 - Report of proposed sale of securities
28/02/202408:11EDGAR2Form 144 - Report of proposed sale of securities
13/02/202422:00EDGAR2Form 8-K - Current report
03/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02/02/202406:52EDGAR2Form 144 - Report of proposed sale of securities
31/01/202406:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/01/202422:05EDGAR2Form 8-K - Current report
30/01/202422:00PRNUSAkebia Secures $55 Million Term Loan Financing
19/01/202407:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/01/202422:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
09/01/202406:08EDGAR2Form 8-K - Current report
08/01/202422:02EDGAR2Form 8-K - Current report
03/01/202406:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
20/12/202322:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
19/12/202306:07EDGAR2Form 8-K - Current report
02/12/202306:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
22/11/202307:07EDGAR2Form 8-K - Current report
20/11/202322:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
08/11/202321:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:33EDGAR2Form 8-K - Current report
08/11/202321:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
03/11/202305:34EDGAR2Form 8-K - Current report
03/11/202305:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
02/11/202305:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..

최근 히스토리

Delayed Upgrade Clock